Compare Abeona Therapeutics Inc (ABEO) vs Direxion Daily CSI China Internet Bull 2X Shares (CWEB) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Direxion Daily CSI China Internet Bull 2X Shares — how do they compare? Abeona Therapeutics Inc trades at $6.7 (market cap $373.32M), while Direxion Daily CSI China Internet Bull 2X Shares trades at $22. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, Direxion Daily CSI China Internet Bull 2X Shares nearer its low. Which is the better fit depends on your goals.
| ABEO | CWEB | |
|---|---|---|
Market Cap | $373.32M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $7.23 | $60.13 |
52-Week Low | $4.17 | $17.70 |
Enterprise Value | $228.22M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
CWEB stock is trading at $20.66, up 5.09% with a bullish technical signal supported by moving averages. The stock shows mixed momentum with RSI indicators suggesting both overbought and neutral conditions. Recent corporate action includes a $0.09 dividend scheduled for June 2026. Trading activity indicates strong interest with the current price near pivot point resistance levels.
The stock's technical strength contrasts with limited fundamental data availability. Investment appeal hinges on upcoming financial disclosures to validate current market positioning. Key risks include reliance on technical momentum without clear fundamental support and market volatility affecting short-term price action.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Direxion Daily CSI China Internet Bull 2X Shares
CWEB is a leveraged ETF that seeks to provide two times (2x) the daily performance of the CSI China Internet Index. It offers magnified exposure to top Chinese internet companies listed on US and Hong Kong exchanges.
Read more on CWEB →
